Literature DB >> 3794400

Cryptosporidiosis in patients with AIDS.

T R Navin, A M Hardy.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3794400     DOI： 10.1093/infdis/155.1.150

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  New mouse models for chronic Cryptosporidium infection in immunodeficient hosts.

Authors:  B L Ungar; J A Burris; C A Quinn; F D Finkelman
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation.

Authors:  P C Okhuysen; C L Chappell; C Kettner; C R Sterling
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 3.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

4.  Causes of chronic diarrhea in patients with AIDS in Thailand: a prospective clinical and microbiological study.

Authors:  S Manatsathit; S Tansupasawasdikul; D Wanachiwanawin; S Setawarin; P Suwanagool; S Prakasvejakit; S Leelakusolwong; B Eampokalap; U Kachintorn
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

5.  Nosocomial outbreak of cryptosporidiosis in AIDS patients.

Authors:  P Ravn; J D Lundgren; P Kjaeldgaard; W Holten-Anderson; N Højlyng; J O Nielsen; J Gaub
Journal:  BMJ       Date:  1991-02-02

Review 6.  Past and future trends of Cryptosporidium in vitro research.

Authors:  Alexander J Bones; Lyne Jossé; Charlotte More; Christopher N Miller; Martin Michaelis; Anastasios D Tsaousis
Journal:  Exp Parasitol       Date:  2018-12-03       Impact factor: 2.011

7.  Genome-wide upstream motif analysis of Cryptosporidium parvum genes clustered by expression profile.

Authors:  Jenna Oberstaller; Sandeep J Joseph; Jessica C Kissinger
Journal:  BMC Genomics       Date:  2013-07-29       Impact factor: 3.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.